Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-11 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-03-19 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
STSA | Satsuma Pharmaceuticals | 6.46 | 0.00 | 0% | 112.5M |
You can purchase shares of Satsuma Pharmaceuticals (NASDAQ: STSA) through any online brokerage.
Other companies in Satsuma Pharmaceuticals’s space includes: Opiant Pharmaceuticals (NASDAQ:OPNT), Baudax Bio (NASDAQ:BXRX) and Cocrystal Pharma (NASDAQ:COCP).
The latest price target for Satsuma Pharmaceuticals (NASDAQ: STSA) was reported by Credit Suisse on 2021-03-02. The analyst firm set a price target for 6.50 expecting STSA to rise to within 12 months (a possible 0.62% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Satsuma Pharmaceuticals (NASDAQ: STSA) is $6.46 last updated Fri Mar 05 2021 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Satsuma Pharmaceuticals.
There is no upcoming split for Satsuma Pharmaceuticals.